z-logo
Premium
Binding and functional characterisation of allosteric agonists at M2 muscarinic acetylcholine receptors
Author(s) -
Gregory Karen Joan,
Hall Nathan E.,
Sexton Patrick M.,
Christopoulos Arthur
Publication year - 2008
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.22.1_supplement.724.6
Subject(s) - allosteric regulation , muscarinic acetylcholine receptor , binding site , chemistry , receptor , allosteric modulator , muscarinic acetylcholine receptor m5 , muscarinic acetylcholine receptor m1 , acetylcholine , pharmacology , biophysics , biochemistry , biology , muscarinic acetylcholine receptor m3
Muscarinic acetylcholine receptors (mAChRs) contain at least one allosteric site that is topographically distinct from the acetylcholine (ACh)‐binding orthosteric site. Although numerous studies have investigated the structural basis of allosteric modulation at these receptors, far less is known about allosteric ligands that activate the receptor in their own right. We generated a number of M 2 mAChRs harboring different orthosteric‐site mutations (W 99 A, Y 403 A), or allosteric‐site mutations ( 172 EDGE 175 ‐QNGQ, Y 177 A), and investigated their impact on the binding and function of the putative allosteric agonists AC‐42, 77‐LH‐28‐1, McN‐A‐343 and N ‐desmethylclozapine (NDMC). As expected, orthosteric site mutations reduced the affinity and/or efficacy of the orthosteric agonists ACh and pilocarpine, whereas the allosteric site mutations had no significant effects. W 99 A and Y 403 A caused significant increases in the affinity (100–300 fold and 3–10 fold respectively) and efficacy of AC‐42 and 77‐LH‐28‐1. NDMC and McN‐A‐343 showed increased efficacy, but not affinity, at Y 403 A and Y 177 A. Homology models of the M 2 mAChR have been developed around the different ligands. The experimental data and modelling together lead to a better understanding of the allosteric binding sites of mAChRs. This work is supported by National Health & Medical Research Council Project Grant No. 400134 and the Dowd Foundation.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here